Use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/37646/2009
Effective from01/08/2012
KeywordsPharmacogenetics, pharmacokinetics, clinical development
DescriptionThis document clarifies the requirements related to the use of pharmacogenetics in the pharmacokinetic evaluation of medicinal products. It applies predominantly to small molecule drugs as genetic effects on the pharmacokinetics of biological drugs today are much less understood.

Document history

First version

Current version

Adopted guideline

Draft guideline

Concept paper

In operation: 01/08/2012–present

Published: 06/05/2010

Published: 23/04/2009

Related content

How helpful is this page?

Average rating:

 Based on 32 ratings

Add your rating:

See all ratings
7 ratings
6 ratings
6 ratings
6 ratings
7 ratings

Tell us more